Cholesterol 7α-hydroxylase (CYP7A1) activity is modified after chronic ingestion of depleted uranium in the rat

被引:19
|
作者
Racine, R. [1 ]
Grandcolas, L. [1 ]
Grison, S. [1 ]
Stefani, J. [1 ]
Delissen, O. [2 ]
Gourmelon, P. [1 ]
Veyssiere, G. [3 ,4 ]
Souidi, M. [1 ]
机构
[1] Inst Radiol Protect & Nucl Safety, Lab Expt Toxicol, F-92262 Fontenay Aux Roses, France
[2] Inst Radiol Protect & Nucl Safety, Lab Expt Toxicol, F-26702 Pierrelatte, France
[3] Clermont Univ, CNRS, UMR 6247, F-63177 Aubiere, France
[4] Ctr Rech Nutr Humaine, F-63177 Aubiere, France
关键词
Cholesterol metabolism; Cytochrome P450; Liver; Depleted uranium; Chronic contamination; Oxysterol; BILE-ACID SYNTHESIS; NUCLEAR RECEPTORS; CHRONIC CONTAMINATION; CHRONIC EXPOSURE; BONE-FORMATION; TERM EXPOSURE; METABOLISM; EXPRESSION; RADIATION; MODULATION;
D O I
10.1016/j.jsbmb.2010.03.066
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Depleted uranium (DU) is a radioactive heavy metal derived from the nuclear energy production. Its wide use in civilian and military items increases the risk of its environmental dissemination, and thus the risk of internal contamination of populations living in such contaminated territories. Previous studies have shown that vitamin D and cerebral cholesterol metabolisms were affected following chronic ingestion of DU. Even more than the brain, the liver is a crucial organ in cholesterol homeostasis since it regulates cholesterol distribution and elimination at body level. The aim of this work was to assess the impact of a low-level chronic ingestion of DU on hepatic cholesterol metabolism. Rats were contaminated with DU in their drinking water at a concentration of 40 mg/l for 9 months. The major effect induced by DU was a decrease of CYP7A1 specific activity (-60%) correlated with a matching decrease of its product 7 alpha-hydroxycholesterol in the plasma. Hepatic gene expression of transporters ABC A1 ABC G5, ABC G8 and of nuclear receptor RXR was increased, whereas that of catabolism enzyme CYP7B1 was decreased. Thus, after a chronic ingestion of DU, rats experience a modulation of cholesterol catabolism but overcome it, since their cholesterolemia is preserved and no pathology is declared. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:60 / 66
页数:7
相关论文
共 50 条
  • [1] Regulation of Diurnal Variation of Cholesterol 7α-hydroxylase (CYP7A1) Activity in Healthy Subjects
    Kovar, J.
    Lenicek, M.
    Zimolova, M.
    Vitek, L.
    Jirsa, M.
    Pitha, J.
    PHYSIOLOGICAL RESEARCH, 2010, 59 (02) : 233 - 238
  • [2] Role of Cholesterol 7α-Hydroxylase (CYP7A1) in Nutrigenetics and Pharmacogenetics of Cholesterol Lowering
    Jaroslav A. Hubacek
    Dagmar Bobkova
    Molecular Diagnosis & Therapy, 2006, 10 : 93 - 100
  • [3] -203A/C POLYMORPHISM OF CHOLESTEROL 7ALPHA-HYDROXYLASE (CYP7A1) GENE AND DIURNAL VARIATION IN CYP7A1 ACTIVITY
    Kovar, J.
    Zimolova, M.
    Lenicek, M.
    Vitek, L.
    Jirsa, M.
    Poledne, R.
    ATHEROSCLEROSIS, 2009, 207 (01) : E9 - E9
  • [4] -203A/C POLYMORPHISM OF CHOLESTEROL 7α-HYDROXYLASE (CYP7A1) GENE AFFECTS CYP7A1 ACTIVITY AFTER SHORT-TERM TREATMENT WITH CHOLESTYRAMINE
    Kovar, J.
    Zimolova, M.
    Lenicek, M.
    Vitek, L.
    Jirsa, M.
    Poledne, R.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 10 - 10
  • [5] Role of cholesterol 7α-hydroxylase (CYP7A1) in nutrigenetics and pharmacogenetics of cholesterol lowering
    Hubacek, Jaroslav A.
    Bobkova, Dagmar
    MOLECULAR DIAGNOSIS & THERAPY, 2006, 10 (02) : 93 - 100
  • [6] -203A/C POLYMORPHISM OF CHOLESTEROL 7α- HYDROXYLASE (CYP7A1) GENE AFFECTS CYP7A1 ACTIVITY AFTER SHORT-TERM TREATMENT WITH CHOLESTYRAMINE
    Kovar, J.
    Zimolova, M.
    Lenicek, M.
    Vitek, L.
    Jirsa, M.
    Poledne, R.
    Pitha, J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 199 - 200
  • [7] Interactions Between Regulatory Variants in CYP7A1 (Cholesterol 7α-Hydroxylase) Promoter and Enhancer Regions Regulate CYP7A1 Expression
    Wang, Danxin
    Hartmann, Katherine
    Seweryn, Michal
    Sadee, Wolfgang
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2018, 11 (10): : e002082
  • [8] Pharmacological modulation of cholesterol 7α-hydroxylase (CYP7A1) as a therapeutic strategy for hypercholesterolemia
    Lim, Megan Yu Cai
    Ho, Han Kiat
    BIOCHEMICAL PHARMACOLOGY, 2024, 220
  • [9] Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype
    Pullingr, CR
    Eng, C
    Salen, G
    Shefer, S
    Batta, AK
    Erickson, SK
    Verhagen, A
    Rivera, CR
    Mulvihill, SJ
    Malloy, MJ
    Kane, JP
    JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (01): : 109 - 117
  • [10] Mechanisms for Increased Expression of Cholesterol 7α-Hydroxylase (Cyp7a1) in Lactating Rats
    Wooton-Kee, Clavia Ruth
    Coy, Donna J.
    Athippozhy, Antony T.
    Zhao, Tianyong
    Jones, Brett R.
    Vore, Mary
    HEPATOLOGY, 2010, 51 (01) : 277 - 285